awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q40232762-12A9E39E-58BB-49B8-B191-BB52BE9E7F49
Q40232762-12A9E39E-58BB-49B8-B191-BB52BE9E7F49
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40232762-12A9E39E-58BB-49B8-B191-BB52BE9E7F49
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.
P50
Q40232762-12A9E39E-58BB-49B8-B191-BB52BE9E7F49
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40232762-12A9E39E-58BB-49B8-B191-BB52BE9E7F49
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f7b9b2d4ff561ba2a71436508f3224142223a862
P1545
12
http://www.w3.org/2001/XMLSchema#string
P50
Peter C Lanyon